DJIA 15,847.21 -357.76 -2.21%
NASDAQ 4,241.63 -121.51 -2.78%
S&P 500 1,839.26 -40.79 -2.17%
market minute promo

Novartis (NYSE: NVS)



company name or ticker
Company Photos
(Click to zoom)

Pre-Market Most Active for Feb 8, 2016 : CBX, NVS, TVIX, AZN, NOK, MT, BCRX, QQQ, FB, XIV, BAC, APO

Pre-Market Most Active for Feb 8, 2016 : CBX, NVS, TVIX, AZN, NOK, MT, BCRX, QQQ, FB, XIV, BAC, APOL

3 Potential Blockbusters Moving the Needle for Big Pharma in 2016

These pharmas have some recently approved drugs that could singlehandedly boost total sales this year.

Biogen Inc. Takes Aim at Johnson & Johnson

Biogen's Samsung Bioepis has Remicade in its crosshairs.

Why Ophthotech Corporation Shares Tumbled 31% in January

The launch of trials in dry age-related macular degeneration failed to spark shares last month.

Valeant's Share Price Continues to Decline

CAH Named Top 25 SAFE Dividend Stock Increasing Payments For Decades

NVS Named Top 10 SAFE International Dividend Stock

Glaxo Tops Q4 Earnings, Revenues Rise Y/Y, 2016 View Intact

ImmunoGen, Inc.'s Earnings Play the Amortization Blues

Keep focused on the pipeline because revenue and earnings are going to be bumpy for some time.

Noteworthy ETF Outflows: VEU, NSRGY, NVS, TM

See More Articles...